Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Phase 2 Single-Arm Trial of High-Dose Precision Targeted Radiation Therapy Added to Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer.
Gensheimer MF, Kotha NV, Vitzthum LK, Chin AL, Jackson S, van 't Erve I, Pratapneni A, Le-Budka ML, Wong S, Brown E, Barnick K, Wakelee HA, Das M, Ramchandran KJ, Myall NJ, Padda S, Marquez CM, Million L, Chen TT, Man MC, Cabebe EC, Chen MC, Hiniker S, Hancock SL, Swift PS, Diehn M, Loo BW, Neal JW. Gensheimer MF, et al. Among authors: ramchandran kj. Int J Radiat Oncol Biol Phys. 2024 Sep 30:S0360-3016(24)03410-2. doi: 10.1016/j.ijrobp.2024.09.038. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 39357790
THE IMPACT OF ROUTINE CARDIAC TROPONIN I-BASED CARDIOTOXICITY SCREENING ON CLINICAL OUTCOMES IN PATIENTS ON CANCER IMMUNOTHERAPY.
Ivanovic M, Chan A, Cheng E, Xu S, Lee C, You J, Franquiz M, Fazal M, Batchelder R, Wu SM, Reddy SA, Katsumoto T, Ramchandran K, Colevas AD, Khan SA, Fan AC, Cheng P, Wakelee H, Witteles R, Neal JW, Waliany S, Zhu H. Ivanovic M, et al. medRxiv [Preprint]. 2024 Jan 24:2024.01.22.24301442. doi: 10.1101/2024.01.22.24301442. medRxiv. 2024. PMID: 38343840 Free PMC article. Preprint.
Phase II Trial of Regorafenib and Oral Methotrexate in Previously Treated Advanced KRAS-Mutant NSCLC.
Aredo JV, Wakelee HA, Ramchandran KJ, Neal JW, Diehn M, Hui AB, Salahudeen A, Kwong B, Berry GJ, Guo HH, Cunanan K, Vali S, Pancirer D, Tsang V, Hwang G, Loza M, Johnson B, Blanchard I, Padda SK. Aredo JV, et al. Among authors: ramchandran kj. JTO Clin Res Rep. 2024 Oct 17;5(12):100741. doi: 10.1016/j.jtocrr.2024.100741. eCollection 2024 Dec. JTO Clin Res Rep. 2024. PMID: 39624248 Free PMC article.
EGFR exon 20 Insertion NSCLC and Response to Platinum-Based Chemotherapy.
Shah MP, Aredo JV, Padda SK, Ramchandran KJ, Wakelee HA, Das MS, Neal JW. Shah MP, et al. Among authors: ramchandran kj. Clin Lung Cancer. 2022 Mar;23(2):e148-e153. doi: 10.1016/j.cllc.2021.07.001. Epub 2021 Jul 19. Clin Lung Cancer. 2022. PMID: 34391686 Free PMC article.
Improved survival and disease control following pembrolizumab-induced immune-related adverse events in high PD-L1 expressing non-small cell lung cancer with brain metastases.
Zhang M, Rodrigues AJ, Pollom EL, Gibbs IC, Soltys SG, Hancock SL, Neal JW, Padda SK, Ramchandran KJ, Wakelee HA, Chang SD, Lim M, Hayden Gephart M, Li G. Zhang M, et al. Among authors: ramchandran kj. J Neurooncol. 2021 Mar;152(1):125-134. doi: 10.1007/s11060-020-03686-3. Epub 2021 Jan 7. J Neurooncol. 2021. PMID: 33415659 Free PMC article.
KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition.
Binkley MS, Jeon YJ, Nesselbush M, Moding EJ, Nabet BY, Almanza D, Kunder C, Stehr H, Yoo CH, Rhee S, Xiang M, Chabon JJ, Hamilton E, Kurtz DM, Gojenola L, Owen SG, Ko RB, Shin JH, Maxim PG, Lui NS, Backhus LM, Berry MF, Shrager JB, Ramchandran KJ, Padda SK, Das M, Neal JW, Wakelee HA, Alizadeh AA, Loo BW Jr, Diehn M. Binkley MS, et al. Among authors: ramchandran kj. Cancer Discov. 2020 Dec;10(12):1826-1841. doi: 10.1158/2159-8290.CD-20-0282. Epub 2020 Oct 18. Cancer Discov. 2020. PMID: 33071215 Free PMC article.
Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition.
Nabet BY, Esfahani MS, Moding EJ, Hamilton EG, Chabon JJ, Rizvi H, Steen CB, Chaudhuri AA, Liu CL, Hui AB, Almanza D, Stehr H, Gojenola L, Bonilla RF, Jin MC, Jeon YJ, Tseng D, Liu C, Merghoub T, Neal JW, Wakelee HA, Padda SK, Ramchandran KJ, Das M, Plodkowski AJ, Yoo C, Chen EL, Ko RB, Newman AM, Hellmann MD, Alizadeh AA, Diehn M. Nabet BY, et al. Among authors: ramchandran kj. Cell. 2020 Oct 15;183(2):363-376.e13. doi: 10.1016/j.cell.2020.09.001. Epub 2020 Oct 1. Cell. 2020. PMID: 33007267 Free PMC article.
15 results